Abortion Drug Bans Make Pharmacies Wary of Common Arthritis Pill

Confusion over prescribing a common arthritis drug post-Roe is prompting demands for state guidance as pharmacies and providers grapple with the fallout of the US Supreme Court’s abortion ruling.

Patient reports of delays or roadblocks in accessing methotrexate have risen on social media since the high court’s ruling triggered abortion bans in 22 states. Prescribers and advocacy groups say state medical and pharmacy boards need to clarify best practices for health professionals who fear legal repercussions for actions that go beyond abortion.

“What we’re seeing is an overreaction to the unknown of some of the laws or regulations that ...